This document discusses recombinant hemoglobin, which is an artificially synthesized hemoglobin used as an oxygen carrier in hemoglobin-based oxygen carriers (HbOCs). Recombinant hemoglobin can be synthesized by expressing mutant globin genes in bacteria like E. coli or plants. It was first developed by Nagai and Thorgerson in 1984 using Plesiomonas shigelloides bacteria, which contain a heme transport system to uptake heme and allow for hemoglobin formation. The document describes using a one plasmid or two plasmid system with BL21(DE3) E. coli cells containing hemoglobin genes and P. shigelloides heme transport genes to produce high levels of recombinant hemoglobin. Some advantages are its universal